These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35832745)

  • 1. The use of genomic variants to drive drug repurposing for chronic hepatitis B.
    Irham LM; Adikusuma W; Perwitasari DA; Dania H; Maliza R; Faridah IN; Santri IN; Phiri YVA; Chong R
    Biochem Biophys Rep; 2022 Sep; 31():101307. PubMed ID: 35832745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach.
    Irham LM; Adikusuma W; Perwitasari DA
    Biochem Biophys Rep; 2022 Dec; 32():101334. PubMed ID: 36090591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis.
    Afief AR; Irham LM; Adikusuma W; Perwitasari DA; Brahmadhi A; Chong R
    Biochem Biophys Rep; 2022 Dec; 32():101337. PubMed ID: 36105612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis.
    Zazuli Z; Irham LM; Adikusuma W; Sari NM
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis.
    Adikusuma W; Chou WH; Lin MR; Ting J; Irham LM; Perwitasari DA; Chang WP; Chang WC
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants.
    Lesmana MHS; Le NQK; Chiu WC; Chung KH; Wang CY; Irham LM; Chung MH
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated genomic analysis to identify druggable targets for pancreatic cancer.
    Mugiyanto E; Adikusuma W; Irham LM; Huang WC; Chang WC; Kuo CN
    Front Oncol; 2022; 12():989077. PubMed ID: 36531045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.
    Jiang DK; Ma XP; Yu H; Cao G; Ding DL; Chen H; Huang HX; Gao YZ; Wu XP; Long XD; Zhang H; Zhang Y; Gao Y; Chen TY; Ren WH; Zhang P; Shi Z; Jiang W; Wan B; Saiyin H; Yin J; Zhou YF; Zhai Y; Lu PX; Zhang H; Gu X; Tan A; Wang JB; Zuo XB; Sun LD; Liu JO; Yi Q; Mo Z; Zhou G; Liu Y; Sun J; Shugart YY; Zheng SL; Zhang XJ; Xu J; Yu L
    Hepatology; 2015 Jul; 62(1):118-28. PubMed ID: 25802187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis.
    Irham LM; Adikusuma W; La'ah AS; Chong R; Septama AW; Angelina M
    Bioengineering (Basel); 2023 Jul; 10(8):. PubMed ID: 37627776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information.
    Adikusuma W; Irham LM; Chou WH; Wong HS; Mugiyanto E; Ting J; Perwitasari DA; Chang WP; Chang WC
    Front Immunol; 2021; 12():724277. PubMed ID: 34721386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New "drugs and targets" in the GWAS era of bipolar disorder.
    Qi HX; Xiao X; Li T; Li M
    Bipolar Disord; 2023 Aug; 25(5):410-421. PubMed ID: 36633396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.
    Khosravi A; Jayaram B; Goliaei B; Masoudi-Nejad A
    Mol Med; 2019 Jun; 25(1):30. PubMed ID: 31221082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals.
    Nishida N; Ohashi J; Sugiyama M; Tsuchiura T; Yamamoto K; Hino K; Honda M; Kaneko S; Yatsuhashi H; Koike K; Yokosuka O; Tanaka E; Taketomi A; Kurosaki M; Izumi N; Sakamoto N; Eguchi Y; Sasazuki T; Tokunaga K; Mizokami M
    Tissue Antigens; 2015 Dec; 86(6):406-12. PubMed ID: 26449183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL16 regulates m
    Gao H; Wang X; Ma H; Lin S; Zhang D; Wu W; Liao Z; Chen M; Li Q; Lin M; Li D
    Front Genet; 2022; 13():996245. PubMed ID: 36406135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population.
    Cheong HS; Lee JH; Yu SJ; Yoon JH; Lee HS; Cheong JY; Cho SW; Park NH; Park BL; Namgoong S; Kim LH; Shin HD; Kim YJ
    Liver Int; 2015 Aug; 35(8):1934-40. PubMed ID: 25404243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive investigating of cytokine and receptor related genes variants in patients with chronic hepatitis B virus infection.
    Yu F; Ma N; Zhang X; Tian S; Geng L; Xu W; Wang M; Jia Y; Liu X; Ma J; Quan Y; Zhang C; Guo L; An W; Liu D
    Cytokine; 2018 Mar; 103():10-14. PubMed ID: 29287219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.
    Kim YJ; Kim HY; Lee JH; Yu SJ; Yoon JH; Lee HS; Kim CY; Cheong JY; Cho SW; Park NH; Park BL; Namgoong S; Kim LH; Cheong HS; Shin HD
    Hum Mol Genet; 2013 Oct; 22(20):4233-8. PubMed ID: 23760081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematically Prioritizing Candidates in Genome-Based Drug Repurposing.
    Challa AP; Lavieri RR; Lewis JT; Zaleski NM; Shirey-Rice JK; Harris PA; Aronoff DM; Pulley JM
    Assay Drug Dev Technol; 2019; 17(8):352-363. PubMed ID: 31769998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population.
    Shin JG; Cheong HS; Lee K; Ju BG; Lee JH; Yu SJ; Yoon JH; Cheong JY; Cho SW; Park NH; Namgoong S; Kim LH; Kim YJ; Shin HD
    Liver Int; 2017 Mar; 37(3):354-361. PubMed ID: 27596359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.